Johnson & Johnson Releases Janssen Vaccine For Emergency Use
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization for Johnson & Johnson’s Janssen COVID-19 vaccine in individuals 18 years of age and older. Johnson & Johnson recently completed the third and final phase of its safety and efficacy trial. The company announced that the Phase 3 ENSEMBLE study demonstrated the […]